Mesothelioma treatment in Istanbul, Turkey
Mesothelioma is a cancer of the thin tissue lining the chest and abdomen, strongly linked to past asbestos exposure — and it is often found late, so for many people treatment is about controlling the disease rather than curing it. Options the NCI lists include surgery for disease that can be removed, pemetrexed-plus-platinum chemotherapy, radiation, and the nivolumab-plus-ipilimumab immunotherapy combination for unresectable pleural disease. Istanbul hospitals offer this full pathway, often at JCI-accredited, state-authorized centers and well below Western-European prices for the same protocol. Every price we show is an illustrative placeholder until verified partner-hospital quotes exist — and you pay the hospital directly, never us. Start with a free 72-hour review of your reports before you decide anything.
What mesothelioma is
The U.S. National Cancer Institute describes malignant mesothelioma as cancer that forms in the mesothelium, the thin layer of tissue that lines the chest and the abdomen. The most common form is pleural mesothelioma, which begins in the lining around the lungs; a less common form, peritoneal mesothelioma, begins in the lining of the abdomen. The NCI links most cases to asbestos exposure, often with a long latency — the disease can appear decades after the exposure.
Diagnosis usually combines imaging — chest X-ray and CT — with a biopsy to confirm the cancer and its type under the microscope. Because early symptoms such as breathlessness or chest and abdominal discomfort are vague and appear so long after exposure, the NCI notes mesothelioma is often found at a more advanced stage, which shapes what treatment can realistically achieve. Browse the wider cancer types hub for related diagnoses.
Treatment options
The modalities the NCI lists for mesothelioma, and an honest note on each:
- Surgery. For disease that can be removed — pleurectomy and decortication, which strips the affected lining, or extrapleural pneumonectomy for pleural disease, and cytoreductive surgery with HIPEC (heated chemotherapy in the abdomen) for peritoneal disease. Whether surgery is possible depends heavily on stage, and it often isn’t once the disease is advanced.
- Chemotherapy. The standard combination is pemetrexed plus a platinum drug such as cisplatin, given to shrink or control the disease. It is a mainstay when surgery is not an option. Cost scales with the number of cycles.
- Radiation therapy. Radiation is used in some plans — for example to ease symptoms or as part of a combined approach. Whether it applies depends on your stage, where the disease sits, and what the treating team is aiming for.
- Immunotherapy. Per the NCI, the checkpoint-inhibitor combination nivolumab plus ipilimumab is FDA-approved as a first-line option for unresectable pleural mesothelioma — disease that cannot be removed by surgery. It is given as infusions, and whether it fits is decided by your tumour type and stage, not a template.
See how these modalities work in general on the treatments & technology hub.
What it costs
There is no single mesothelioma price, because the cost is driven by whether surgery is possible and how extensive it is, whether HIPEC is used for peritoneal disease, the number of chemotherapy cycles, whether radiation is added, and above all whether immunotherapy such as nivolumab plus ipilimumab is used — those drugs are priced per cycle and can dominate the total over months of treatment. Every figure OncologyIstanbul™ publishes today is an illustrative placeholder pending verified partner-hospital quotes, and each is itemized so you can hold a real quote up against it line by line. See the Turkey Oncology Price Index or the full cancer treatment cost in Turkey breakdown.
The hospital, verified
We don’t show a wall of smiling surgeons or a “ranked” list — those are the easiest things to fabricate. Instead, you’re matched to one state-authorized Istanbul partner hospital whose thoracic and surgical oncology subspecialty fits your diagnosis, and you can verify its authorization against the Republic of Turkey Ministry of Health’s own records and its JCI accreditation in JCI’s public directory before you commit. Named specialist profiles appear only when a verified, consented physician is behind the name. See the full guide to cancer hospitals in Istanbul and how to check one yourself.
Where this fits
This is one diagnosis within the broader cancer treatment in Istanbul pillar. If you want your own reports read first, a free second opinion organizes and verifies your pathology and imaging into a plain-language case file in your language before you decide whether to travel.
Related cancers
You might also look at
Check everything here — us included
Common questions
Can I get mesothelioma treatment in Turkey?
Yes. Istanbul hospitals provide the full mesothelioma pathway the U.S. National Cancer Institute describes — surgery for disease that can be removed, such as pleurectomy and decortication or extrapleural pneumonectomy for pleural disease and cytoreductive surgery with HIPEC for peritoneal disease, chemotherapy built on pemetrexed plus a platinum drug, radiation therapy in some plans, and the nivolumab-plus-ipilimumab immunotherapy combination for unresectable pleural disease. Many centers hold JCI accreditation and Turkish Ministry of Health state authorization, both of which you can check yourself before you commit. The honest first step is a free case review of your pathology and imaging so the plan is understood before you travel.
Is mesothelioma curable?
We have to be honest here: often not. The NCI notes that mesothelioma is frequently found at a later stage, partly because symptoms are vague and appear decades after asbestos exposure, and for many people treatment is aimed at controlling the disease and easing symptoms rather than curing it. When the cancer is caught early and can be fully removed by surgery, longer-term control is more realistic, especially for peritoneal disease treated with cytoreduction and HIPEC. Anyone who promises you a guaranteed cure is not being straight with you. A case review will tell you plainly what your reports do and don't yet establish about your options.
What is the nivolumab-plus-ipilimumab immunotherapy option?
It is a two-drug immunotherapy combination. Per the NCI, nivolumab and ipilimumab are checkpoint inhibitors that release brakes on the immune system so it can attack the cancer, and together they are FDA-approved as a first-line option for unresectable malignant pleural mesothelioma — that is, pleural disease that cannot be removed by surgery. They are given as infusions rather than as an operation, and like all cancer drugs they carry their own side effects that a medical oncologist monitors. Whether this combination fits your case depends on your tumour type and stage. This is general information, not a treatment recommendation.
How much does mesothelioma treatment cost in Istanbul?
There is no single figure, because the cost is driven by whether surgery is possible and how extensive it is, whether HIPEC is used for peritoneal disease, the number of chemotherapy cycles, whether radiation is added, and above all whether immunotherapy such as nivolumab plus ipilimumab is used — those drugs are priced per cycle and can dominate the total over months of treatment. Istanbul typically runs well below Western-European prices for the same protocol, but every figure OncologyIstanbul™ publishes today is an illustrative placeholder pending verified partner-hospital quotes, itemized so you can check a real written quote line by line. See the Turkey Oncology Price Index for current ranges.
Start with a free 72-hour case review
Send your pathology and imaging. Get a verified case file in your language — free, confidential, no obligation.
This page is general information, not medical advice. Medical facts are grounded in the U.S. National Cancer Institute; prices shown are illustrative placeholders pending verified partner-hospital quotes, not offers. Every cancer case is individual; assessments are based on the reports you provide and do not replace in-person examination.